Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Canopy Growth Corp (CGC)

35.52   2.61 (7.93%) 01-27 05:35
Open: 33.18 Pre. Close: 32.91
High: 36.15 Low: 33.2
Volume: 9,127,839 Market Cap: 13,266M
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. As of February 14, 2020, it operated 28 cannabis retail stores under the Tweed or Tokyo Smoke name. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 36.184 - 36.359 36.359 - 36.51
Low: 32.806 - 32.996 32.996 - 33.16
Close: 35.219 - 35.531 35.531 - 35.8

Technical analysis

as of: 2021-01-26 4:42:10 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 42.22     One year: 49.32
Support: Support1: 28.67    Support2: 24.05
Resistance: Resistance1: 36.15    Resistance2: 42.22
Pivot: 32.24
Moving Average: MA(5): 33.88     MA(20): 30.42
MA(100): 22.82     MA(250): 19.20
MACD: MACD(12,26): 2.16     Signal(9): 1.90
Stochastic oscillator: %K(14,3): 86.77     %D(3): 85.98
RSI: RSI(14): 70.56
52-week: High: 36.15  Low: 9.00  Change(%): 51.0
Average Vol(K): 3-Month: 693313  10-Days: 559196

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CGC has closed below upper band by 11.1%. Bollinger Bands are 46.8% wider than normal. The large width of the bands suggest high volatility as compared to CGC's normal range. The bands have been in this wide range for 12 bars. This is a sign that the current trend might continue.

Headline News

Tue, 26 Jan 2021
Canopy Growth to Report Third Quarter Fiscal 2021 Financial Results on February 9, 2021 - Yahoo Finance

Tue, 26 Jan 2021
Canopy Growth, Martha Stewart Launch New Line Of CBD Products 'To Enrich The Lives' Of Dogs - Benzinga

Tue, 26 Jan 2021
What is the Market's View on Canopy Growth Corp (CGC) Stock's Price and Volume Trends - InvestorsObserver

Sun, 24 Jan 2021
Marijuana Investors: Canopy Growth (TSX:WEED) Could Skyrocket Back to All-Time Highs - The Motley Fool Canada

Thu, 21 Jan 2021
Canopy Growth CEO On Launch Of CBD Beverage Line Quatreau: 'Our First Foray Into Mood Modulation' - Benzinga

Wed, 20 Jan 2021
Cramer Gives His Opinion On Canopy Growth, Quanta Services And More - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 374
Shares Float (M) 226
% Held by Insiders 39.05
% Held by Institutions 12.51
Shares Short (K) 33,610
Shares Short P. Month (K)

Stock Financials

EPS -1.790
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 5.280
Profit Margin
Operating Margin
Return on Assets (ttm) -6.8
Return on Equity (ttm) -30.8
Qtrly Rev. Growth 76.6
Gross Profit (p.s.) 0.281
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -19.84
PEG Ratio
Price to Book value 6.73
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.